Sales decline 31.31% to Rs 24.57 crore
Net Loss of Sharon Bio-Medicine reported to Rs 21.83 crore in the quarter ended September 2017 as against net loss of Rs 153.77 crore during the previous quarter ended September 2016. Sales declined 31.31% to Rs 24.57 crore in the quarter ended September 2017 as against Rs 35.77 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales24.5735.77 -31 OPM %-67.60-392.20 -PBDT-4.64-176.05 97 PBT-5.88-181.06 97 NP-21.83-153.77 86Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
